TIMM50 and inborn mitochondrial metabolism disorder: Using quantitative proteomics of patient fibroblasts and a CRISPR-Cas9 mediated TIMM50 HEK293 cell model of disease, we have established the first proteomic map of mitochondrial disease associated with TIMM50 pathogenic variants.